Ampio Pharm Stock Performance

AMPE Stock  USD 0.01  0.00  0.00%   
Ampio Pharm holds a performance score of 19 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 42.47, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ampio Pharm will likely underperform. Use Ampio Pharm variance, value at risk, as well as the relationship between the Value At Risk and rate of daily change , to analyze future returns on Ampio Pharm.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ampio Pharm are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Ampio Pharm exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow12.7 M
Free Cash Flow-8.6 M
  

Ampio Pharm Relative Risk vs. Return Landscape

If you would invest  10.00  in Ampio Pharm on November 10, 2025 and sell it today you would lose (9.00) from holding Ampio Pharm or give up 90.0% of portfolio value over 90 days. Ampio Pharm is currently generating 65.6458% in daily expected returns and assumes 261.6466% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Ampio, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Ampio Pharm is expected to generate 322.03 times more return on investment than the market. However, the company is 322.03 times more volatile than its market benchmark. It trades about 0.25 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Ampio Pharm Target Price Odds to finish over Current Price

The tendency of Ampio Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.01 90 days 0.01 
about 73.68
Based on a normal probability distribution, the odds of Ampio Pharm to move above the current price in 90 days from now is about 73.68 (This Ampio Pharm probability density function shows the probability of Ampio Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 42.47 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ampio Pharm will likely underperform. In addition to that Ampio Pharm has an alpha of 62.2524, implying that it can generate a 62.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Ampio Pharm Price Density   
       Price  

Predictive Modules for Ampio Pharm

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ampio Pharm. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0150.51
Details
Intrinsic
Valuation
LowRealHigh
0.000.0450.54
Details

Ampio Pharm Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ampio Pharm is not an exception. The market had few large corrections towards the Ampio Pharm's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ampio Pharm, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ampio Pharm within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
62.25
β
Beta against Dow Jones42.47
σ
Overall volatility
0.11
Ir
Information ratio 0.25

Ampio Pharm Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ampio Pharm for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ampio Pharm can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ampio Pharm is way too risky over 90 days horizon
Ampio Pharm has some characteristics of a very speculative penny stock
Ampio Pharm appears to be risky and price may revert if volatility continues
Ampio Pharm has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (8.63 M) with profit before overhead, payroll, taxes, and interest of 0.
Ampio Pharm currently holds about 23.25 M in cash with (8.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Ampio Pharm Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ampio Pink Sheet often depends not only on the future outlook of the current and potential Ampio Pharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ampio Pharm's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding810.1 K
Cash And Short Term Investments4.1 M

Ampio Pharm Fundamentals Growth

Ampio Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ampio Pharm, and Ampio Pharm fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ampio Pink Sheet performance.

About Ampio Pharm Performance

By analyzing Ampio Pharm's fundamental ratios, stakeholders can gain valuable insights into Ampio Pharm's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ampio Pharm has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ampio Pharm has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.

Things to note about Ampio Pharm performance evaluation

Checking the ongoing alerts about Ampio Pharm for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ampio Pharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ampio Pharm is way too risky over 90 days horizon
Ampio Pharm has some characteristics of a very speculative penny stock
Ampio Pharm appears to be risky and price may revert if volatility continues
Ampio Pharm has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (8.63 M) with profit before overhead, payroll, taxes, and interest of 0.
Ampio Pharm currently holds about 23.25 M in cash with (8.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating Ampio Pharm's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ampio Pharm's pink sheet performance include:
  • Analyzing Ampio Pharm's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ampio Pharm's stock is overvalued or undervalued compared to its peers.
  • Examining Ampio Pharm's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Ampio Pharm's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ampio Pharm's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Ampio Pharm's pink sheet. These opinions can provide insight into Ampio Pharm's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ampio Pharm's pink sheet performance is not an exact science, and many factors can impact Ampio Pharm's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Ampio Pink Sheet analysis

When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon